An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Raja GR Edula, Michael F PiccoMayo Clinic, Jacksonville, Florida, USAAbstract: Treatment options for Crohn’s disease have evolved beyond the early goals of induction and remission and are now more focused on preventing complications by altering the natural history of the disease. The a...
Main Authors: | Raja GR Edula, Michael F Picco |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-11-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/an-evidence-based-review-of-natalizumab-therapy-in-the-management-of-c-a3752 |
Similar Items
-
Infliximab therapy in pediatric Crohn’s disease: a review
by: Kalyan Ray Parashette, et al.
Published: (2010-06-01) -
Oropharyngeal Crohn’s disease
by: Rachid Mohamed, et al.
Published: (2008-12-01) -
Adalimumab for the treatment of Crohn’s disease
by: Andrea Cassinotti, et al.
Published: (2008-09-01) -
Sarcoidosis complicating treatment with natalizumab for Crohn's disease
by: Parisinos, C, et al.
Published: (2011) -
Burden of Crohn’s disease: economics and quality of life aspects in Italy
by: Benedini V, et al.
Published: (2012-07-01)